Evaluation of Standardized Usage of Oral Antidiabetic Agents in Inpatients' Prescriptions
10.3969/j.issn.1008-049X.2018.01.032
- VernacularTitle:某院病区口服抗糖尿病药物用药的规范性评价
- Author:
Yimei LI
1
;
Ting XU
;
Qian XU
;
Bin XU
Author Information
1. 上海交通大学医学院附属瑞金医院北院药剂科 上海200025
- Keywords:
Oral antidiabetic agents;
Medical advice;
Standardization;
Rational drug use
- From:
China Pharmacist
2018;21(1):125-128
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the standardized usage of oral antidiabetic agents in inpatients to provide reference for the pre -scription standardization .Methods:A retrospective study was used to evaluate the prescriptions of oral antidiabetic agents in inpatients during January and March in 2017 , and statistical analysis was conducted on drug usage and standardization evaluation .Results:There were 886 medication plans including 4,397 prescriptions, which involved in 13 kinds of antidiabetic agents .Metformin and acarbose a-gents were used most frequently .The non-standardization rate was 70.54％with 66.03％unlabeled accurate time for oral administra-tion and 4.51％ labeled wrong time for oral administration .Twelve antidiabetic agents existed non-standardized applications ( >50％) .Conclusion:The main problem in the non-standardized usage of antidiabetic agents is leaving the special time for oral adminis -tration of antidiabetic agents out of account , which not only affect the best efficacy , but also reduce patients ' compliance .It' s neces-sary to standardize the prescriptions of antidiabetic agents to improve the standardization of medication therapy .
